端粒酶抑制剂

an-Bin Zhang,Xiao-Liang Wang,Wen Liu.Design,synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors[J]. anic & Medicinal Chemistry,2012,21(20): 635-636 .Р[14] N. Csaba,A. Sanchez,M.J. Alonso PLGA: poloxamer and PLGA: poloxamine blend nanostructures as carriers for nasal gene delivery[J]Journal of Controlled Release, 2006,113 :164–172.Р[15] S. Azarmi,W.H. Roa,R. Löbenberg Targeted delivery of nanoparticles for the treatment of lung diseases[J]. Advanced Drug Delivery Reviews,2008,60: 863–875.Р[16] 张火俊,陆建平,杨继金等. 经动脉灌注端粒酶抑制剂AZT对大鼠walker-256肝肿瘤的影响[J]. 放射学实践,2012,27(1):17-19.Р[17] 张静,刘照旭,杨金玲. B I BR1532对 p53和 pRb功能缺陷的肿瘤细胞生长抑制作用的研究[J]. 山东大学学报(医学版)2006,44: 11132-1120.Р[18] 左利娟,李洪雪. 端粒酶抑制剂研究进展[J]. 中国实用医,2010,5(5):225-227.